Dammam Valley to acquire majority in Arcensus GmbH; accelerating Whole Genome Sequencing in genetic diagnostics, delivering breakthrough technologies in genomic bioinformatics
Sep 05, 2022 20:00 HKT |  |
|
Novotech at ESMO Congress 2022 - New Data Shows 100% Oncology Trials Growth in APAC
Sep 05, 2022 18:00 HKT |  |
|
EC Healthcare Chairman Mr. Eddy Tang Increases Shareholding, Demonstrating Full Confidence in the Group's Future Development
Sep 02, 2022 17:31 HKT |  |
|
Legend Capital: The Logic of Technology Investment Has Changed
Sep 02, 2022 17:05 HKT |  |
|
Younger Colorectal Cancer Population Highlights the Importance of Early Screening, Highly Sensitive Test Product Prenetics has Launched the Market
Sep 02, 2022 14:33 HKT | |
|
APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report
Sep 02, 2022 14:00 HKT | |
|
CT Event Asia to host ASEAN Healthcare Transformation Summit 2022
Sep 01, 2022 15:50 HKT |  |
|
Transcenta Holding (06628): Product pipeline progressing well with significant competitive differentiation
Sep 01, 2022 10:31 HKT | |
|
Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio
Aug 30, 2022 21:00 HKT |  |
|
Malaysian Genomics Reports RM28.36 Million Full-Year Revenue
Aug 30, 2022 14:00 HKT |  |
|
Strengthen technological innovation, Basecare Medical Announces 2022 Interim Results
Aug 29, 2022 18:30 HKT |  |
|
Avance Clinical Sponsors Biotech Company of the Year Awards at Informa Pharma Intelligence Awards 2022
Aug 29, 2022 18:00 HKT |  |
|
Malaysian Genomics Signs MoU with Ajlan to explore distribution of biopharmaceutical and genetic screening services in MENA region
Aug 29, 2022 14:00 HKT | |
|
Sirnaomics Achieves 100% Complete Response in Phase II Clinical Trial of STP705 for Treatment of Cutaneous Basal Cell Carcinoma
Aug 29, 2022 12:46 HKT | |
|
Sirnaomics Advances GalAhead(TM)-Based RNAi Therapeutics for Treatment of Complement-Related Diseases
Aug 26, 2022 20:15 HKT | |
|
Zhaoke Ophthalmology Announces 2022 Interim Results
Aug 24, 2022 20:37 HKT |  |
|
Sinomab Announces IND Application of SN1011 for the Treatment of Neuromyelitis Optica Spectrum Disorder Approved by NMPA
Aug 24, 2022 08:05 HKT |  |
|
Avantor and Avantor Foundation Make a Difference by Providing Critical Health Services for Vulnerable Communities in Singapore
Aug 24, 2022 07:55 HKT |  |
|
Oculis announces publication of Phase 2 data showing topical eye drops anti-TNFa agent licaminlimab (OCS-02) relieves persistent ocular discomfort in severe dry eye disease
Aug 23, 2022 20:37 HKT |  |
|
Sino Biopharmaceutical (1177.HK) Announces 2022 lnterim Results, Revenue up by 5.9% to RMB15.19 billion
Aug 23, 2022 19:51 HKT |  |
|